CD8(+)T cell–specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8(+)T cell accumulation in tumors

BACKGROUND: Increased infiltration of CD8(+)T cells into tumors has a positive impact on survival. Our previous study showed that doxorubicin (Dox) plus interleukin-12 (IL-12) boosted the accumulation of CD8(+)T cells in tumors and had a greater antitumor effect than did either agent alone. The purp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jiemiao, Zhu, Shiguo, Xia, Xueqing, Zhang, Liangfang, Kleinerman, Eugenie S, Li, Shulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938086/
https://www.ncbi.nlm.nih.gov/pubmed/24565056
http://dx.doi.org/10.1186/1476-4598-13-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938086/
https://www.ncbi.nlm.nih.gov/pubmed/24565056
http://dx.doi.org/10.1186/1476-4598-13-34

Ejemplares similares